BOOST Pharma: Funding, Investors & Team (Sep 2026)
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
BOOST Pharma has raised $1.6M across 1 funding round on record, the most recent a Convertible Note of $1.6M announced in Oct 2025.
That round is below the $42M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BOOST Pharma Company Profile and Key Stats
Latest funding round on record: Oct 2025.
BOOST Pharma Funding Rounds
BOOST Pharma Founders and Leadership Team
Contact details for the BOOST Pharma team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →BOOST Pharma Funding Compared to Other Biotechnology Startups
BOOST Pharma's latest round of $1.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BOOST Pharma in Biotechnology and Copenhagen
Companies Similar to BOOST Pharma
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain…
Weike Bio is a gene therapy drug development company.
Twinpig Biolab researches and develops anticancer drugs.
Kunshi Biotechnology is a drug developer with an emphasis on solid tumor cells.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and…
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific…
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal…
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
Step Pharma is a biotechnology company.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
ThirdLaw Molecular pioneers revolutionary Spiroligomer™ molecules for safer, more targeted, effective disease…
BOOST Pharma Funding FAQs
What does BOOST Pharma do?
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
How much funding has BOOST Pharma raised?
BOOST Pharma has raised $1.6M across 1 round on record. The most recent is a Convertible Note of $1.6M announced in Oct 2025.
When did BOOST Pharma last raise funding?
BOOST Pharma's most recent funding round on record is a Convertible Note of $1.6M, announced in Oct 2025.
Who is the CEO of BOOST Pharma?
Evert Kueppers is listed as CEO at BOOST Pharma.
Where is BOOST Pharma headquartered?
BOOST Pharma is based in Copenhagen, Denmark.
How many employees does BOOST Pharma have?
BOOST Pharma is in the 1-10 employee band.
How does BOOST Pharma's funding compare to other Biotechnology startups?
BOOST Pharma's latest round of $1.6M is below the $42M median round size for Biotechnology companies on FundedIQ across 20 tracked companies over the last two years.
About FundedIQ's BOOST Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BOOST Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.